Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Xeris Biopharma Holdings Inc. buy SVB Leerink LLC

Xeris Biopharma Holdings Inc.
Start price
€4.21
10.03.25 / 50%
Target price
€5.52
10.03.26
Performance (%)
17.02%
End price
€4.92
11.03.26
Summary
This prediction ended on 11.03.26 with a price of €4.92. The prediction had a final performance of 17.02%. SVB_Leerink_LLC has a follow-up prediction for Xeris Biopharma Holdings Inc. where he still thinks Xeris Biopharma Holdings Inc. is a Buy. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Xeris Biopharma Holdings Inc. - - -
iShares Core DAX® -1.862% -1.624% 0.645%
iShares Nasdaq 100 -3.322% 3.321% 32.004%
iShares Nikkei 225® -2.299% 3.437% 51.012%
iShares S&P 500 -1.313% 2.435% 23.006%

Comments by SVB_Leerink_LLC for this prediction

In the thread Xeris Biopharma Holdings Inc. diskutieren
Prediction Buy
Perf. (%) 17.02%
Target price 5.522
Change
Ends at 10.03.26

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target raised by analysts at Leerink Partners from $5.00 to $6.00. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat

SVB Leerink LLC 
0
Report Share
10.03.25
In the thread Trading Xeris Biopharma Holdings Inc.
Prediction Buy
Perf. (%) 17.02%
Target price 5.522
Change
Ends at 10.03.26

Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten

SVB Leerink LLC 
0
Report Share
11.03.26

Current prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc.

buy
Xeris Biopharma Holdings Inc.

Start price
Target price
Perf. (%)
€6.61
22.08.25
€7.75
22.08.26
-17.97%
28.05.26

SVB Leerink LLC 
22.08.25 50%